106 related articles for article (PubMed ID: 19787264)
1. BRD8 is a potential chemosensitizing target for spindle poisons in colorectal cancer therapy.
Yamada HY; Rao CV
Int J Oncol; 2009 Nov; 35(5):1101-9. PubMed ID: 19787264
[TBL] [Abstract][Full Text] [Related]
2. C20orf20 (MRG-binding protein) as a potential therapeutic target for colorectal cancer.
Yamaguchi K; Sakai M; Shimokawa T; Yamada Y; Nakamura Y; Furukawa Y
Br J Cancer; 2010 Jan; 102(2):325-31. PubMed ID: 20051959
[TBL] [Abstract][Full Text] [Related]
3. Cellular Depletion of BRD8 Causes p53-Dependent Apoptosis and Induces a DNA Damage Response in Non-Stressed Cells.
Lashgari A; Fauteux M; Maréchal A; Gaudreau L
Sci Rep; 2018 Sep; 8(1):14089. PubMed ID: 30237520
[TBL] [Abstract][Full Text] [Related]
4. Bromodomain protein BRD8 regulates cell cycle progression in colorectal cancer cells through a TIP60-independent regulation of the pre-RC complex.
Yamaguchi K; Nakagawa S; Saku A; Isobe Y; Yamaguchi R; Sheridan P; Takane K; Ikenoue T; Zhu C; Miura M; Okawara Y; Nagatoishi S; Kozuka-Hata H; Oyama M; Aikou S; Ahiko Y; Shida D; Tsumoto K; Miyano S; Imoto S; Furukawa Y
iScience; 2023 Apr; 26(4):106563. PubMed ID: 37123243
[TBL] [Abstract][Full Text] [Related]
5. The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer.
Yoshida Y; Wang IC; Yoder HM; Davidson NO; Costa RH
Gastroenterology; 2007 Apr; 132(4):1420-31. PubMed ID: 17408638
[TBL] [Abstract][Full Text] [Related]
6. MiR-185 attenuates androgen receptor function in prostate cancer indirectly by targeting bromodomain containing 8 isoform 2, an androgen receptor co-activator.
Jiang CY; Ruan Y; Wang XH; Zhao W; Jiang Q; Jing YF; Han BM; Xia SJ; Zhao FJ
Mol Cell Endocrinol; 2016 May; 427():13-20. PubMed ID: 26940039
[TBL] [Abstract][Full Text] [Related]
7. Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the β-catenin pathway in colorectal cancer.
Kang JH; Jang JE; Mishra SK; Lee HJ; Nho CW; Shin D; Jin M; Kim MK; Choi C; Oh SH
J Ethnopharmacol; 2015 Sep; 173():303-12. PubMed ID: 26210065
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of miR-203 sensitizes paclitaxel (Taxol)-resistant colorectal cancer cells through targeting the salt-inducible kinase 2 (SIK2).
Liu Y; Gao S; Chen X; Liu M; Mao C; Fang X
Tumour Biol; 2016 Sep; 37(9):12231-12239. PubMed ID: 27236538
[TBL] [Abstract][Full Text] [Related]
9. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
[TBL] [Abstract][Full Text] [Related]
10. Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.
Wang T; Ning K; Sun X; Zhang C; Jin LF; Hua D
BMC Cancer; 2018 Feb; 18(1):207. PubMed ID: 29463225
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis and suppression of ERCC1 expression by the potent amonafide analogue 8-c in human colorectal carcinoma cells.
Wang Z; Liang X; Cheng Z; Xu Y; Yin P; Zhu H; Li Q; Qian X; Liu J
Anticancer Drugs; 2013 Apr; 24(4):355-65. PubMed ID: 23426174
[TBL] [Abstract][Full Text] [Related]
12. Targeted molecular therapy of the PI3K pathway: therapeutic significance of PI3K subunit targeting in colorectal carcinoma.
Rychahou PG; Jackson LN; Silva SR; Rajaraman S; Evers BM
Ann Surg; 2006 Jun; 243(6):833-42; discussion 843-4. PubMed ID: 16772787
[TBL] [Abstract][Full Text] [Related]
13. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
14. Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas.
Violette S; Festor E; Pandrea-Vasile I; Mitchell V; Adida C; Dussaulx E; Lacorte JM; Chambaz J; Lacasa M; Lesuffleur T
Int J Cancer; 2003 Jan; 103(2):185-93. PubMed ID: 12455032
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats.
Janakiram NB; Steele VE; Rao CV
Cancer Prev Res (Phila); 2009 Jan; 2(1):52-9. PubMed ID: 19139018
[TBL] [Abstract][Full Text] [Related]
16. DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer.
Martinez-Useros J; Rodriguez-Remirez M; Borrero-Palacios A; Moreno I; Cebrian A; Gomez del Pulgar T; del Puerto-Nevado L; Vega-Bravo R; Puime-Otin A; Perez N; Zazo S; Senin C; Fernandez-Aceñero MJ; Soengas MS; Rojo F; Garcia-Foncillas J
BMC Cancer; 2014 Dec; 14():965. PubMed ID: 25515240
[TBL] [Abstract][Full Text] [Related]
17. Silencing GOLPH3 gene expression reverses resistance to cisplatin in HT29 colon cancer cells via multiple signaling pathways.
Zhou ZP; Wang LP; Hong ZS; Qiu CZ; Wang MZ; Chen ZX; Tang LF; Yu WS; Wang CX
Int J Oncol; 2018 Sep; 53(3):1183-1192. PubMed ID: 30015866
[TBL] [Abstract][Full Text] [Related]
18. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
19. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.
Ladner RD; Lynch FJ; Groshen S; Xiong YP; Sherrod A; Caradonna SJ; Stoehlmacher J; Lenz HJ
Cancer Res; 2000 Jul; 60(13):3493-503. PubMed ID: 10910061
[TBL] [Abstract][Full Text] [Related]
20. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
